Form 4: Amprius CTO Sells Shares After Option Exercise

Amprius Technologies' Chief Technology Officer, Stefan Constantin Ionel, exercised stock options and subsequently sold 39,690 shares of common stock for approximately $476,350 under a pre-arranged 10b5-1 trading plan.

Summary

• Stefan Constantin Ionel, Chief Technology Officer of Amprius Technologies, Inc. (AMPX), engaged in transactions on January 28, 2026.
• Exercised options to acquire 90 shares of common stock at $0.62 per share.
• Exercised options to acquire 39,600 shares of common stock at $0.05 per share.
• Sold a total of 39,690 shares of common stock at an average price of $12.0018 per share.
• The sales were executed under a Rule 10b5-1 trading plan adopted on September 11, 2025.
• Following these transactions, the reporting person directly beneficially owns 748,696 shares, which includes 585,697 restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be perceived negatively, the execution under a pre-established 10b5-1 plan mitigates concerns about opportunistic trading, suggesting personal financial planning rather than a change in company outlook.

Positives

• The CTO exercised options at significantly lower prices ($0.62 and $0.05) compared to the sale price ($12.0018), indicating a profitable transaction for the individual.
• The transactions were conducted under a Rule 10b5-1 trading plan, which suggests pre-planned sales and can mitigate concerns about opportunistic insider selling.

Negatives

• The Chief Technology Officer sold a substantial number of shares (39,690 shares) for approximately $476,350, which could be interpreted by some investors as a lack of confidence in the company's near-term stock price appreciation, despite being part of a 10b5-1 plan.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors as they can sometimes signal management's perception of the company's valuation. However, sales executed under a Rule 10b5-1 plan are pre-scheduled and often for personal financial planning reasons, making them less indicative of a change in management's outlook compared to unscheduled sales.

Comparison to Industry Standards

• Insider selling, even under a 10b5-1 plan, is a common occurrence across industries for personal financial management.
• Without specific company performance metrics or industry-specific benchmarks in this Form 4, a direct comparison to industry standards for operational or financial results is not applicable.
• The volume of shares sold relative to the CTO's total holdings (including RSUs) is a factor investors typically consider when evaluating the significance of such transactions.

Related Party Transactions

• The transactions reported are related party transactions, as they involve an executive officer of Amprius Technologies, Inc. exercising stock options and selling company stock.

Stakeholder Impact

• Shareholders may interpret the sale as a signal, though the 10b5-1 plan suggests it's for personal financial planning. The sale could add minor selling pressure to the stock.
• No direct impact on employees is mentioned, but general sentiment around insider transactions can affect morale.

Key Dates

Recommendation

While the CTO's sale of shares might raise questions, the execution under a pre-planned 10b5-1 trading plan suggests it's for personal financial management rather than a reflection of a negative outlook on the company's future. Given the context of a planned transaction, it does not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while monitoring future company developments.

Keywords

Amprius Technologies, AMPX, Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Chief Technology Officer, Stefan Constantin Ionel, 10b5-1 Plan, Equity Transaction